FASLODEX (Fulvestrant)-250mg

FASLODEX (Fulvestrant) is hormone therapy fights cancer as an “estrogen receptor down regulator.” It binds to the estrogen receptor site in competition with estrogen in the body.  Once it binds to the site it causes the receptors to break down, thereby preventing normal cellular response to estrogen.

It is used to treat advanced breast cancer or breast cancer that has spread to other parts of the body (metastatic) in postmenopausal women, with disease progression following antiestrogen therapy.

Enquiry Now
Categories: ,

Additional information

Trade Name

FASLODEX

Generic Name

Fulvestrant

Manufacturer

AstraZeneca Pharmaceuticals LP

Drug Type

Oncology

Indication

Breast Cancer

Doasage Form

Injectible

Packaging

2 x 5ml 250mg